|
|
 |
A study of 51 HIV-positive subjects with a history of a CD4 count below 200 or an AIDS- defining illness concluded that the experimental drug SP-303 is safe and well-tolerated and that SP-303 may be effective in
reducing stool weight and frequency in AIDS-associated diarrhea.
A three-fold greater reduction in stool weight was observed after four days in SP-303 treated patients as compared to patients receiving placebo.
Editor's Note: from the 12th World AIDS Conference, Geneva, Switzerland, June 28-July 3
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
